Results for tag: "Systemic Mastocytosis"

Systemic Mastocytosis (SM) is a rare, chronic disorder of the bone marrow and other organs caused by an abnormal increase in mast cells. It is classified as a myeloproliferative disorder and is part of the spectrum of mast cell activation disorders. Symptoms of SM can include skin lesions, abdominal pain, flushing, diarrhea, and anaphylaxis. It is typically treated with medications such as antihistamines, mast cell stabilizers, and corticosteroids. SM is a rare disorder, and the prevalence is unknown. It is more common in adults than in children, and is more common in men than in women. Diagnosis is based on clinical presentation, laboratory tests, and bone marrow biopsy. Treatment is based on the severity of the symptoms and the organs affected. The Systemic Mastocytosis market is part of the larger Allergy and Immunology market. It is a niche market, with few companies offering products and services related to SM. Companies in the market include Novartis, Pfizer, and Teva Pharmaceuticals. Show Less Read more